Diabetes Care:脉压升高预测糖尿病偶发房颤

2012-08-07 高晓方 医学论坛网

  意大利学者的一项研究表明,在2型糖尿病患者中,脉压升高为偶发性房颤的独立预测因素。论文于2012年7月30日在线发表于《糖尿病护理》(Diabetes Care)。   此项研究共纳入350例2型糖尿病患者。受试者基线时均无房颤,随访时间为10年。每年度实施标准心电图检查,并由同一心内科医生在受累患者中确认偶发性房颤的诊断。   结果显示,随访期间共有32例(9.1%)受试者出现

  意大利学者的一项研究表明,在2型糖尿病患者中,脉压升高为偶发性房颤的独立预测因素。论文于2012年7月30日在线发表于《糖尿病护理》(Diabetes Care)。

  此项研究共纳入350例2型糖尿病患者。受试者基线时均无房颤,随访时间为10年。每年度实施标准心电图检查,并由同一心内科医生在受累患者中确认偶发性房颤的诊断。

  结果显示,随访期间共有32例(9.1%)受试者出现偶发性房颤。对年龄、性别、BMI、糖尿病持续时间、左心室肥大、高血压治疗、肾功能障碍、冠心病病史、心衰和轻度心瓣膜病进行校正之后,基线脉压与房颤发病率增高具有相关性(P<0.01)。

  链接:Filippo Valbusa,Stefano Bonapace,Lorenzo Bertolini,Luciano Zenari,Guido Arcaro,Giovanni Targher.Increased Pulse Pressure Independently Predicts Incident Atrial Fibrillation in Patients With Type 2 Diabetes.May 20, 2012.



    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1900984, encodeId=6e9a190098443, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jan 24 10:15:00 CST 2013, time=2013-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759175, encodeId=28511e59175a5, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Jan 27 13:15:00 CST 2013, time=2013-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636543, encodeId=f591163654395, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Feb 28 20:15:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1900984, encodeId=6e9a190098443, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jan 24 10:15:00 CST 2013, time=2013-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759175, encodeId=28511e59175a5, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Jan 27 13:15:00 CST 2013, time=2013-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636543, encodeId=f591163654395, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Feb 28 20:15:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1900984, encodeId=6e9a190098443, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jan 24 10:15:00 CST 2013, time=2013-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759175, encodeId=28511e59175a5, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Jan 27 13:15:00 CST 2013, time=2013-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636543, encodeId=f591163654395, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Feb 28 20:15:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]